PH24605A - Pentadiene amides - Google Patents

Pentadiene amides

Info

Publication number
PH24605A
PH24605A PH37197A PH37197A PH24605A PH 24605 A PH24605 A PH 24605A PH 37197 A PH37197 A PH 37197A PH 37197 A PH37197 A PH 37197A PH 24605 A PH24605 A PH 24605A
Authority
PH
Philippines
Prior art keywords
lower alkyl
aryl
hydrogen
independently
het
Prior art date
Application number
PH37197A
Other languages
English (en)
Inventor
Robert William Guthrie
Richard Wightman Kierstead
Jefferson Wright Tilley
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH24605A publication Critical patent/PH24605A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH37197A 1987-07-10 1988-07-08 Pentadiene amides PH24605A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/072,389 US4788206A (en) 1987-07-10 1987-07-10 Pentadieneamides

Publications (1)

Publication Number Publication Date
PH24605A true PH24605A (en) 1990-08-17

Family

ID=22107243

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37197A PH24605A (en) 1987-07-10 1988-07-08 Pentadiene amides

Country Status (21)

Country Link
US (1) US4788206A (ko)
EP (1) EP0299379B1 (ko)
JP (1) JPS6431766A (ko)
KR (1) KR890001989A (ko)
AT (1) ATE88466T1 (ko)
AU (1) AU626526B2 (ko)
CZ (1) CZ394991A3 (ko)
DE (1) DE3880387D1 (ko)
DK (1) DK378188A (ko)
ES (1) ES2054740T3 (ko)
FI (1) FI883290A (ko)
HU (1) HU205902B (ko)
IL (1) IL87017A0 (ko)
MC (1) MC1954A1 (ko)
MX (1) MX9203599A (ko)
NO (1) NO883084L (ko)
NZ (1) NZ225327A (ko)
PH (1) PH24605A (ko)
PT (1) PT87953B (ko)
YU (1) YU46716B (ko)
ZA (1) ZA884857B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225307A (en) * 1987-07-10 1991-06-25 Hoffmann La Roche Heterocyclic containing alkene derivatives and pharmaceutical compositions
US5192766A (en) * 1989-04-28 1993-03-09 Sankyo Company, Limited N-acryloylpiperazine derivatives, their preparation and their use as PAF antagonists
US5369106A (en) * 1989-04-28 1994-11-29 Sankyo Company, Limited N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists
DK0900200T5 (da) * 1996-04-23 2010-01-11 Targacept Inc Farmaceutiske sammensætninger til forebyggelse og behandling af sygdom i centralnervesystemet
KR100568997B1 (ko) * 1996-04-23 2006-12-15 타가셉트 인코포레이티드 중추신경계질환의예방및치료를위한약제학적조성물
AU2652397A (en) * 1996-05-13 1997-12-05 Nippon Shinyaku Co. Ltd. Substituted ethylene compounds and drugs
ATE270277T1 (de) * 1997-12-11 2004-07-15 Janssen Pharmaceutica Nv Anilide als vitamin-a-säure-mimetika
US6232316B1 (en) 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
DE19828463A1 (de) * 1998-06-26 1999-12-30 Basf Ag 4,4-Diarylbutadiene als wasserlösliche photostabile UV-Filter für kosmetische und pharmazeutische Zubereitungen
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
AU5326100A (en) * 1999-06-07 2000-12-28 Targacept, Inc. Pharmaceutical compositions and methods for use
DE60325834D1 (de) * 2002-02-20 2009-03-05 Abbott Lab Kondensierte azabicyclischeverbindungen als inhibitoren des vanilloid-rezeptors 1 (vr1)
WO2004078144A2 (en) * 2003-03-05 2004-09-16 Celgene Corporation Diphenylethylene compounds and uses thereof
US8013006B2 (en) * 2004-07-14 2011-09-06 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) * 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) * 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) * 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (ja) * 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Ｃ型肝炎を治療するためのチエノピリジン
EP2050734A1 (en) 2006-07-13 2009-04-22 Kyowa Hakko Kirin Co., Ltd. Pentadienamide derivative
US7767705B2 (en) 2006-08-25 2010-08-03 Abbott Laboratories Compounds that inhibit TRPV1 and uses thereof
MX2011001887A (es) * 2008-08-22 2011-04-04 Baxter Int Derivados de bencil carbonato polimericos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072649A (en) * 1963-01-08 S-tmalkoxycinnamamide derivatives
US4568687A (en) * 1983-02-28 1986-02-04 American Cyanamid Company N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
US4568685A (en) * 1984-02-29 1986-02-04 American Cyanamid Company N-[(1H-1,2,4-Triazol-1-yl)alkyl]-arylamides
US4542145A (en) * 1984-02-29 1985-09-17 American Cyanamid Company Substituted N-[(1H-1,2,4-triazol-1-yl)-alkyl]heteroarylcarboxamides
US4673684A (en) * 1984-04-04 1987-06-16 Terumo Corporation Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient
JPS6144870A (ja) * 1984-08-10 1986-03-04 Terumo Corp 不飽和脂肪酸アミド誘導体およびこれを含有する血小板凝集抑制剤
JPS6144869A (ja) * 1984-08-10 1986-03-04 Terumo Corp イミダゾ−ル誘導体およびこれを含有する血小板凝集抑制剤
JPS6212757A (ja) * 1985-07-10 1987-01-21 Yoshitomi Pharmaceut Ind Ltd 桂皮酸アミド誘導体
US4778796A (en) * 1985-07-19 1988-10-18 Dainippon Pharmaceutical Co., Ltd. ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same
JPH06144869A (ja) * 1992-11-10 1994-05-24 Matsunami Glass Kogyo Kk バイオ担体用多孔質ガラス

Also Published As

Publication number Publication date
EP0299379A1 (de) 1989-01-18
KR890001989A (ko) 1989-04-07
AU626526B2 (en) 1992-08-06
HU205902B (en) 1992-07-28
PT87953B (pt) 1995-03-01
NO883084L (no) 1989-01-11
HUT48594A (en) 1989-06-28
CZ394991A3 (en) 1993-01-13
PT87953A (pt) 1989-06-30
JPS6431766A (en) 1989-02-02
US4788206A (en) 1988-11-29
ES2054740T3 (es) 1994-08-16
YU132488A (en) 1991-02-28
ATE88466T1 (de) 1993-05-15
FI883290A (fi) 1989-01-11
DK378188A (da) 1989-01-11
YU46716B (sh) 1994-04-05
NO883084D0 (no) 1988-07-08
DE3880387D1 (de) 1993-05-27
MX9203599A (es) 1992-07-01
MC1954A1 (fr) 1989-06-30
FI883290A0 (fi) 1988-07-08
ZA884857B (en) 1989-04-26
IL87017A0 (en) 1988-12-30
AU1885188A (en) 1989-01-12
DK378188D0 (da) 1988-07-07
NZ225327A (en) 1991-08-27
EP0299379B1 (de) 1993-04-21

Similar Documents

Publication Publication Date Title
PH24605A (en) Pentadiene amides
HUT56082A (en) Process for producing 4-benzoyl-isoxazol derivatives and fungicide compositions containing them as active components
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
NO892058L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzamider.
IL70528A (en) Pharmaceutical compositions comprising derivatives of naphthalene-or azanaphthalenecarboxamide,novel derivatives of such compounds and processes for their preparation
TW206970B (ko)
DE3561513D1 (en) 3n-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions
IL96762A0 (en) Pyridyl cyclopropane derivatives,process for their preparation and fungicidal compositions containing them
EP0150015A3 (en) Norbornane and norbornene carboxylic acid amides, process for their preparation and their use as medicines
EP0309425A3 (en) New heterocyclic derivatives
HUT50464A (en) Process for producing phenothiazin derivatives
HUT60498A (en) Process for producing 2-(substituted pyrrolidinylthio)-carbapenem derivatives and pharmaceutical compositions comprising such compounds
HUT38625A (en) Process for preparing 1,5-benzoxathiepine derivatives and pharmaceutical compositions containing such compounds
IT1214632B (it) Glicin ammidi n-alchil(ene)-n-(0,0-disostituito-tiofosforil)- n',n'-disostituite, procedimento per la loro preparazione e acaricidi, insetticidi e fungicidi contenenti questi composti come ingrediente attivo.
HU902029D0 (en) Process for producing thio-formamide derivatives and pharmaceutical preparatives containing these compounds
GB2014995A (en) (Cycloalkyl)-alkylbenzamides
ATE131057T1 (de) 8-chloro-benzothiazepin-verbindung zur prophylaxe und behandlung der folgen der zerebralen nekrose von neurozyten.
JPS56169656A (en) Bis(substituted phenoxyacetic acid)-n- alkyldialkanolamine, its manufacture and brain trouble treating agent containing it as major component
HK1011863A1 (en) New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them